HUTCHMED (LON:HCM) Stock Price Crosses Below 200-Day Moving Average of $267.29

HUTCHMED (China) Limited (LON:HCM) shares passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 267.29 ($3.33) and traded as low as GBX 267 ($3.32). HUTCHMED shares last traded at GBX 268 ($3.34), with a volume of 66,901 shares.

HUTCHMED Trading Down 1.1 %

The company has a 50 day moving average of GBX 252.95 and a 200-day moving average of GBX 267.29. The company has a debt-to-equity ratio of 11.59, a quick ratio of 2.97 and a current ratio of 2.72. The stock has a market cap of £2.26 billion, a price-to-earnings ratio of 2,680.00 and a beta of 0.68.

About HUTCHMED

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors.